AXONE-Acute II: Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy
AXONE-Acute-2
1 other identifier
interventional
39
2 countries
7
Brief Summary
Pilot study to evaluate the performance of a lead below 2 French with specific distal shape to deliver efficient LV pacing
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2020
Shorter than P25 for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 5, 2019
CompletedFirst Posted
Study publicly available on registry
November 7, 2019
CompletedStudy Start
First participant enrolled
January 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 29, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 29, 2020
CompletedFebruary 6, 2026
February 1, 2026
9 months
November 5, 2019
February 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
LV Bi-zone pacing success rate
Percent of patients where the placement of the AXONE lead provides two distant LV pacing vectors matching: Pacing Threshold ≤ 3.5V/0.5ms.
30 min
LV pacing success rate
Percent of patients where the placement of the AXONE lead allows at least one LV pacing vectors matching: Pacing Threshold ≤ 3.5V/0.5ms.
30 min
Secondary Outcomes (8)
Device or Implant testing procedure-related Adverse Events
1 month post intervention
Electrical performance (1)
30 min
Electrical performance (2)
30 min
AXONE Implant Efficiency (1)
30 min
AXONE Implant Efficiency (2)
30 min
- +3 more secondary outcomes
Study Arms (1)
Implant test procedure
EXPERIMENTALImplant test procedure with new LV quadripolar lead before a standard implantation for Cardiac resynchronisation therapy
Interventions
Implant test procedure with new LV quadripolar lead before a standard implantation for Cardiac resynchronisation therapy
Eligibility Criteria
You may qualify if:
- Male or female patient aged ≥18 years old.
- Patient presenting a CRT-P or CRT-D indication according to the latest ESC guidelines1.
- Primary implant of a CRT device (including upgrade from a single or dual-chamber pacemaker or ICD).
- Signed and dated informed consent.
You may not qualify if:
- Class IV of NYHA (ambulatory or not).
- Allergy to contrast media used for imaging during cardiac catheterization.
- Severe Renal Failure (clearance of creatinine according to Modification of diet in renal disease formula (MDRD) \< 30ml/mn/m²).
- Previous failure of catheterization of the coronary sinus, or previous failure of left ventricular lead implantation.
- Already included in another clinical study involving intra-cardiac active implantable device, or participation to any other clinical trial in the last 2 weeks.
- Vulnerable patient such as person deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision).
- Known pregnancy, breastfeeding or women in childbearing age without an adequate contraceptive method with a known failure rate \< 1%.-
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Rouenlead
- MicroPort CRMcollaborator
Study Sites (7)
Bordeaux University Hospital
Bordeaux, France
Clermont-Ferrand University Hospital
Clermont-Ferrand, France
Lille University Hospital
Lille, France
Rennes University Hospital
Rennes, France
Rouen University Hospital
Rouen, France
Hospital Universitari Germans Trias i Pujol
Badalona, Spain
Hospital Universitario y Politécnico La Fe
Valencia, Spain
Study Officials
- PRINCIPAL INVESTIGATOR
Frédéric ANSELME, Pr
University Hospital, Rouen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 5, 2019
First Posted
November 7, 2019
Study Start
January 2, 2020
Primary Completion
September 29, 2020
Study Completion
September 29, 2020
Last Updated
February 6, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share